v3.21.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Preferred Stock – Series C-3, Series E and Series G
Accumulated Other Comprehensive Income (Loss)
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 25,665 $ 242 $ 97,257 $ 218,944,268 $ (195,421,172) $ 23,646,260
Balance (in Shares) at Dec. 31, 2019 25,665,350 241,623        
Stock issued in connection with ATM sale of common stock, net $ 368     2,469,569   2,469,937
Stock issued in connection with ATM sale of common stock, net (in Shares) 368,144          
Stock issued in connection with warrants exercised $ 92     411,659   411,751
Stock issued in connection with warrants exercised (in Shares) 91,500          
Payment of financing fees       (47,024)   (47,024)
Issuance of vested restricted stock $ 2     (2)    
Issuance of vested restricted stock (in Shares) 2,385          
Stock-based compensation       1,372,204   1,372,204
Other comprehensive income     8,333     8,333
Net loss         (9,339,991) (9,339,991)
Balance at Jun. 30, 2020 $ 26,127 $ 242 105,590 223,150,674 (204,761,163) 18,521,470
Balance (in Shares) at Jun. 30, 2020 26,127,379 241,623        
Balance at Mar. 31, 2020 $ 26,127 $ 242 90,736 222,455,084 (200,978,739) 21,593,450
Balance (in Shares) at Mar. 31, 2020 26,127,067 241,623        
Issuance of vested restricted stock (in Shares) 312          
Stock-based compensation       695,590   695,590
Other comprehensive income     14,854     14,854
Net loss         (3,782,424) (3,782,424)
Balance at Jun. 30, 2020 $ 26,127 $ 242 105,590 223,150,674 (204,761,163) 18,521,470
Balance (in Shares) at Jun. 30, 2020 26,127,379 241,623        
Balance at Dec. 31, 2020 $ 33,558 $ 242 102,006 261,536,061 (217,448,855) 44,223,012
Balance (in Shares) at Dec. 31, 2020 33,558,096 241,623        
Stock issued in connection with ATM sale of common stock, net $ 3,738     41,451,892   41,455,630
Stock issued in connection with ATM sale of common stock, net (in Shares) 3,737,862          
Stock issued in connection with warrants exercised, cash $ 31     164,855   164,886
Stock issued in connection with warrants exercised, cash (in Shares) 31,407          
Stock issued in connection with warrants exercised, cashless $ 70     (70)    
Stock issued in connection with warrants exercised, cashless (in Shares) 70,269          
Stock issued in connection with options exercised $ 33     137,002   137,035
Stock issued in connection with options exercised (in Shares) 32,734          
Conversion of Series G preferred shares to common stock $ 556 $ (10)   (546)    
Conversion of Series G preferred shares to common stock (in Shares) 556,069 (10,001)        
Conversion of Series C-3 preferred shares to common stock $ 100 $ (50)   (50)    
Conversion of Series C-3 preferred shares to common stock (in Shares) 100,000 (50,000)        
Stock-based compensation       2,741,680   2,741,680
Other comprehensive loss     (2,825)     (2,825)
Net loss         (11,849,873) (11,849,873)
Balance at Jun. 30, 2021 $ 38,086 $ 182 99,181 306,030,824 (229,298,728) 76,869,545
Balance (in Shares) at Jun. 30, 2021 38,086,437 181,622        
Balance at Mar. 31, 2021 $ 38,046 $ 182 98,826 304,843,806 (224,665,793) 80,315,067
Balance (in Shares) at Mar. 31, 2021 38,046,092 181,622        
Stock issued in connection with warrants exercised, cash $ 7     39,950   39,957
Stock issued in connection with warrants exercised, cash (in Shares) 7,611          
Stock issued in connection with options exercised $ 33     137,002   137,035
Stock issued in connection with options exercised (in Shares) 32,734          
Stock-based compensation       1,010,066   1,010,066
Other comprehensive loss     355     355
Net loss         (4,632,935) (4,632,935)
Balance at Jun. 30, 2021 $ 38,086 $ 182 $ 99,181 $ 306,030,824 $ (229,298,728) $ 76,869,545
Balance (in Shares) at Jun. 30, 2021 38,086,437 181,622